BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21137081)

  • 1. Combinatorial vascular targeting in translational medicine.
    Staquicini FI; Moeller BJ; Arap W; Pasqualini R
    Proteomics Clin Appl; 2010 Jul; 4(6-7):626-32. PubMed ID: 21137081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage display technology for stem cell delivery and systemic therapy.
    Staquicini FI; Sidman RL; Arap W; Pasqualini R
    Adv Drug Deliv Rev; 2010 Sep; 62(12):1213-6. PubMed ID: 20932865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage display for epitope determination: a paradigm for identifying receptor-ligand interactions.
    Rowley MJ; O'Connor K; Wijeyewickrema L
    Biotechnol Annu Rev; 2004; 10():151-88. PubMed ID: 15504706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-directed profiling: applications to target drug discovery in cancer.
    Staquicini FI; Pasqualini R; Arap W
    Expert Opin Drug Discov; 2009 Jan; 4(1):51-9. PubMed ID: 23480336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage peptide display.
    Newton J; Deutscher SL
    Handb Exp Pharmacol; 2008; (185 Pt 2):145-63. PubMed ID: 18626602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of receptor ligands with phage display peptide libraries.
    Koivunen E; Arap W; Rajotte D; Lahdenranta J; Pasqualini R
    J Nucl Med; 1999 May; 40(5):883-8. PubMed ID: 10319765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope mapping using combinatorial phage-display libraries: a graph-based algorithm.
    Mayrose I; Shlomi T; Rubinstein ND; Gershoni JM; Ruppin E; Sharan R; Pupko T
    Nucleic Acids Res; 2007; 35(1):69-78. PubMed ID: 17151070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors.
    Balestrieri ML; Napoli C
    Eur J Cancer; 2007 May; 43(8):1242-50. PubMed ID: 17449238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From combinatorial chemistry to cancer-targeting peptides.
    Aina OH; Liu R; Sutcliffe JL; Marik J; Pan CX; Lam KS
    Mol Pharm; 2007; 4(5):631-51. PubMed ID: 17880166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring protein-protein interactions with phage display.
    Sidhu SS; Fairbrother WJ; Deshayes K
    Chembiochem; 2003 Jan; 4(1):14-25. PubMed ID: 12512072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affibody-mediated transferrin depletion for proteomics applications.
    Grönwall C; Sjöberg A; Ramström M; Höidén-Guthenberg I; Hober S; Jonasson P; Ståhl S
    Biotechnol J; 2007 Nov; 2(11):1389-98. PubMed ID: 17639529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular addresses of tumors: selection by in vivo phage display.
    Li XB; Schluesener HJ; Xu SQ
    Arch Immunol Ther Exp (Warsz); 2006; 54(3):177-81. PubMed ID: 16736105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerating the discovery of new drug targets with chemical proteomics.
    Cheung AK; Jain RK
    IDrugs; 2010 Dec; 13(12):862-8. PubMed ID: 21154144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond receptor expression levels: the relevance of target accessibility in ligand-directed pharmacodelivery systems.
    Ozawa MG; Zurita AJ; Dias-Neto E; Nunes DN; Sidman RL; Gelovani JG; Arap W; Pasqualini R
    Trends Cardiovasc Med; 2008 May; 18(4):126-32. PubMed ID: 18555185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient isolation of peptide ligands for the endothelial cell protein C receptor (EPCR) using candidate receptor phage display biopanning.
    White SJ; Simmonds RE; Lane DA; Baker AH
    Peptides; 2005 Jul; 26(7):1264-9. PubMed ID: 15949645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo phage display--a discovery tool in molecular biomedicine.
    Bábíčková J; Tóthová Ľ; Boor P; Celec P
    Biotechnol Adv; 2013 Dec; 31(8):1247-59. PubMed ID: 23623852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of phage display to discovery of tumor-specific homing peptides: developing strategies for therapy and molecular imaging of cancer.
    Seung-Min L; Gil-Suk Y; Eun-Sang Y; Tae-Gyun K; In-San K; Byung-Heon L
    Methods Mol Biol; 2009; 512():355-63. PubMed ID: 19347288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.